Atlas Trials

Study of the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 Hypertension

Clinical trial NCT00772577 · COMPLETED

Trial details

NCT number
NCT00772577
Sponsor
Novartis
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hypertension
Start date
2008-08-01
Primary completion
2009-03-01
Enrollment
386

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.